Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series Ltd: World’s leading Event Organizer
As per available reports about 17 Conferences, 6 Workshops and 9 Relevant Journals are presently dedicated exclusively to Omics technologies and about 325 articles are being published on Omics Technologies.
OMICS has become the new mantra in molecular research. “Omics” technologies include genomics, transcriptomics, proteomics and metabolomics. Omics aims at the collective characterization and quantification of pools of biological molecules that translate into the structure, function, and dynamics of an organism or organisms.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
OMICS International Conference series focuses to enhance knowledge dissemination among its varied range of participants including eminent speakers, renowned scientists, industrialists from top notch companies, young researchers and students. OMICS International Pharma conferences foster the better understanding of latest scientific researches by providing a global exposure to its participants where they can associate with relatable professionals. The scope of these gatherings is further extended by encompassing remarking key areas like Pharmaceutical Regulatory Affairs, Mass Spectrometry, Separation Techniques, Toxicology , Therapeutic Drug Monitoring and Toxicogenomics, Pain Medicine, Clinical Pharmacy, GMP and GLP quality control, followed by Bioavailability and Bioequivalence studies, Biosimilars and Pharmacognosy.
Scope and Importance:
Omics Technologies (transcriptomics, proteomics and metabolomics) reveal the gene product biological function. The “-omic-” technologies are high-throughput technologies and they increase substantially the number of proteins/genes that can be detected simultaneously to relate complex mixtures to complex effects in the form of gene/protein expression profiles. The nontargeted identification of all gene products (transcripts, proteins, and metabolites) present in a specific biological sample is the primary aim of omics technologies. “omics” technologies have opened new avenues towards biomarker discovery, identification of signaling molecules associated with cell growth, cell death, cellular metabolism and early detection of cancer. Omics will not only have an impact on our understanding of biological processes, but the prospect of more accurately diagnosing and treating disease will soon become a reality.
The -omics technologies will continue to contribute to our understanding of toxicity mechanisms. Regulators are interested in these new technologies but are still sorting out how to incorporate the new information and technologies in regulatory decision making. For example, the US Food and Drug Administration’s Pharmacogenomic Data Submissions guidance document encourages the voluntary submission of genomics data but notes that the field of pharmacogenomics is still in its early developmental stages.
OMICS International is planning to conduct conference on Omics Technologies. The conference on Omics technologies will discuss on advances in Epigenetic inheritance and reprogramming, Single cell epigenetics, Epigenetic regulation on single molecule level and application of these technologies in assessment of toxicity and toxicogenomics and other fields.
In 2013, the global transcriptomics market was valued at $1,743.2. This is expected to reach $3,773.0 million by 2019 at a CAGR of 13.7% from 2014 to 2019. The market is fragmented as by technology and applications. By technology market comprises of microarray, PCR, sequencing, and RNAi gene silencing technologies whereas, the market by applications include clinical diagnostics, drug discovery, and toxicogenomics.
Due to increasing technological advancements in the field of ‘omics’ and also the increased application of RNA analysis in biomarker field the market has witnessed a significant growth. This growth is hampered to a certain extent due to high costs of investments.
The market for RNA Analysis technologies market includes microarray, PCR, sequencing including Sanger sequencing and NGS, and RNAi gene silencing. PCR technology has dominated the market due to its increasing application in RNA sequencing.. However, the sequencing segment including NGS is expected to grow at a higher CAGR due the increase in read lengths facilitated by this technology, reduced costs, and faster sequencing from existing platforms.
North America holds the largest share of the global transcriptomics market. However, in the forthcoming years, developing regions such as Asia-Pacific (Japan, China, and India) and Latin America are expected to form new revenue-generating pockets for the market players. Economic developments and growing government funding to support new product developments are the key factors driving the growth of market in developing regions.
The market is dominated by players such as Affymetrix Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), GE Healthcare (U.S.), Illumina Inc. (U.S.), Qiagen N.V. (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Sigma Aldrich (U.S.), Fluidigm Corporation (U.S.) and Thermofisher Scientific Inc. (U.S.)
This page will be updated regularly.
This page was last updated on 15th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising